Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.14 USD
Change Today -0.24 / -3.76%
Volume 254.9K
RTIX On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

rti surgical inc (RTIX) Snapshot

Open
$6.23
Previous Close
$6.38
Day High
$6.32
Day Low
$6.10
52 Week High
07/31/15 - $7.48
52 Week Low
10/23/14 - $3.50
Market Cap
353.8M
Average Volume 10 Days
353.7K
EPS TTM
$0.17
Shares Outstanding
57.6M
EX-Date
--
P/E TM
35.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for RTI SURGICAL INC (RTIX)

rti surgical inc (RTIX) Related Bloomberg News

View More Bloomberg News

rti surgical inc (RTIX) Related Businessweek News

No Related Businessweek News Found

rti surgical inc (RTIX) Details

RTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes orthopedic and other surgical implants for use in various surgical procedures worldwide. The company provides natural tissue implants, as well as metal and synthetic implants for the treatment of spinal and other orthopedic disorders. It processes donated human musculoskeletal and other tissues, including bone, cartilage, tendons, ligaments, fascia lata, pericardium, sclera, cornea, and dermal tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company’s implants are used in the fields of spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic, surgical specialties, and dental. RTI Surgical, Inc. markets its products through its direct distribution force, as well as through a network of independent distributors to hospitals and surgeons. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida.

1,102 Employees
Last Reported Date: 03/4/15
Founded in 1997

rti surgical inc (RTIX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $550.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $336.0K
Executive Vice President of Tissue-Based Impl...
Total Annual Compensation: $330.0K
Chief Scientific Officer and Executive Vice P...
Total Annual Compensation: $334.0K
Corporate Secretary
Total Annual Compensation: $330.0K
Compensation as of Fiscal Year 2014.

rti surgical inc (RTIX) Key Developments

RTI Surgical Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Revises Earnings Guidance for the Full Year of 2015; Provides Earnings Guidance for the Third Quarter of 2015

RTI Surgical Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, revenues were $71,609,000 against $66,029,000 a year ago. Operating income was $5,715,000 against $4,410,000 a year ago. Income before income tax provision was $5,428,000 against $3,925,000 a year ago. Net income applicable to common shares was $2,685,000 against $1,577,000 a year ago. Net income per diluted common share was $0.05 against $0.03 a year ago. EBITDA was $9,314,000 against $7,441,000 a year ago. Adjusted EBITDA was $10,775,000 against $8,806,000 a year ago. Net cash provided by operating activities was $5,711,000 against $2,622,000 a year ago. Purchases of property, plant and equipment was $4,312,000 against $3,536,000 a year ago. Patent and acquired intangible asset costs were $94,000 against $59,000 a year ago. For the six months, revenues were $139,643,000 against $126,774,000 a year ago. Operating income was $11,879,000 against $922,000 a year ago. Income before income tax provision was $11,298,000 against $82,000 a year ago. Net income applicable to common shares was $5,619,000 against net loss applicable to common shares of $1,483,000 a year ago. Net income per diluted share was $0.10 against net loss per common diluted share of $0.03 a year ago. EBITDA was $18,658,000 against $6,845,000 a year ago. Adjusted EBITDA was $21,478,000 against $15,180,000 a year ago. Net cash provided by operating activities was $6,717,000 against net cash used in operating activities of $685,000 a year ago. Purchases of property, plant and equipment was $8,577,000 against $8,472,000 a year ago. Patent and acquired intangible asset costs were $116,000 against $276,000 a year ago. For the full year of fiscal 2015, the company is narrowing its full year revenue guidance for 2015. The company now expects full year revenues for 2015 to be between $282 million and $286 million, as compared to prior guidance of between $281 million and $286 million. The company now expects full year net income per fully diluted common share to be in the range of $0.20 to $0.23 based on 58.7 million fully diluted common shares outstanding, as compared to prior guidance of $0.19 to $0.23. For 2015, the company anticipates being cash flow positive from operations. For the third quarter of 2015, the company expects revenues to be between $69 million and $70 million and net income per fully diluted common share to be approximately $0.05, based on 58.8 million fully diluted shares outstanding. The third quarter has traditionally been impacted by seasonal trends in surgeries, Hutchison said, however, based on its results from the first half.

RTI Surgical Inc. to Report Q2, 2015 Results on Jul 30, 2015

RTI Surgical Inc. announced that they will report Q2, 2015 results at 8:30 AM, US Eastern Standard Time on Jul 30, 2015

RTI Surgical Inc., Q2 2015 Earnings Call, Jul 30, 2015

RTI Surgical Inc., Q2 2015 Earnings Call, Jul 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RTIX:US $6.14 USD -0.24

RTIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $0.58 USD +0.005
AngioDynamics Inc $14.56 USD -0.20
Exactech Inc $18.87 USD -0.74
Orthofix International NV $36.94 USD -0.54
SeaSpine Holdings Corp $13.93 USD -0.20
View Industry Companies
 

Industry Analysis

RTIX

Industry Average

Valuation RTIX Industry Range
Price/Earnings 54.6x
Price/Sales 1.3x
Price/Book 2.1x
Price/Cash Flow 36.9x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RTI SURGICAL INC, please visit www.rtisurgical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.